Course Offerings for those training in Interventional Radiology
The courses listed on this page are designed for Integrated Interventional Radiology (IR) residents or Independent Residents who have finished a traditional Radiology residency and are training in an IR program. Attendees will have the opportunity for hands-on training with guide wires, stents, image interpretation, closure devices and more.
To express interest in registering for a course, reach out to your local Abbott representative or request information directly from our Medical Education team with one of the request information links below.
EndoFellows Medical Education Program
This course utilizes a system-based teaching method that includes didactic modules, interactive case reviews, and 3 hands-on workshops covering guide wires, vessel closure and Supera™ Peripheral Stent System deployment. Fellows will be challenged to rethink treatment strategy and product selection based on the clinical insight and treatment rationale from the program faculty. The focus of this course is to review and understand clinical presentations, diagnostic techniques, and medical management strategies for patients with Peripheral Artery Disease (PAD). More specifically, understanding the current literature, indications, approach, equipment, interventional techniques, and management of complications in the following areas:
Superficial Femoral Artery (SFA) Disease
Iliac Disease
Tibial Disease
Carotid Artery Disease
Subclavian/Brachiocephalic Disease
Venous Disease
Designed For: Interventional Radiology, Interventional Cardiology and Vascular Surgery Fellows
Abbott partners with societies and conferences to give attendees access to hands-on practice with Abbott products, procedures and techniques while attending the conference. Most sessions offer access to key opinion leaders in the field in addition to product specialists.
Designed For: Interventional Cardiology, Interventional Radiology and Vascular Surgery Fellows
For more information on any of our programs, please contact your Abbott representative or view our course catalog with available dates and registration.
Indications:
The Supera™ Peripheral Stent System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and / or proximal popliteal artery with reference vessel diameters of 4.0 to 7.5 mm, and lesion lengths up to 140 mm.
Contraindications:
The Supera™ Peripheral Stent System is contraindicated in:
Patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon or proper placement of the stent or stent delivery system.
Patients who cannot receive antiplatelet or anticoagulation therapy. Based on in vivo thrombogenicity testing, the device should not be used in patients who cannot be anticoagulated as there may be some thrombus formation in the absence of anticoagulation.
Warnings:
This device is intended for single-use only. Do not reuse. Do not resterilize. Do not use if the package is opened or damaged.
Use this device prior to the “Use By” date as specified on the device package label. Store in a dry, dark, cool place.
DO NOT use if it is suspected that the sterility of the device has been compromised.
Persons with known hypersensitivities to Nitinol and / or its components (e.g. nickel-titanium) may suffer an allergic reaction to this implant.
Administer appropriate antiplatelet therapy pre- and post-procedure.
Careful attention should be paid when sizing and deploying the stent to prevent stent elongation. In the SUPERB clinical study, stent elongation was associated with a decrease in patency at 12 months.
Precautions: The Supera™ Peripheral Stent System should only be used by physicians and medical personnel trained in vascular interventional techniques and trained on the use of this device.
The long-term safety and effectiveness of the Supera™ Peripheral Stent System has not been established beyond three years.
The safety and effectiveness of the Supera Peripheral Stent System has not been established in patients who:
are less than 18 years old
are pregnant or lactating
have in-stent restenosis of the target lesion
have known hypersensitivity to any component of the stent system (e.g., nickel)
cannot tolerate contrast media and cannot be pre-treated
have uncontrolled hypercoagulability and / or other coagulopathy
This device is not designed for use with contrast media injection systems or power injection systems.
The flexible design of the Supera stent may result in variation in the deployed stent length.
Magnetic Resonance Imaging (MRI) Safety Information
Nonclinical testing has demonstrated that the Supera™ Stent, in single and in overlapped configurations up to 250 mm in length, is MR Conditional. A patient with this device can be safely scanned in an MR system meeting the following conditions:
Static magnetic field of 1.5 or 3.0 Tesla
Maximum spatial gradient magnetic field of 2,500 Gauss/cm (25 T/m)
Maximum MR whole-body-averaged specific absorption rate (SAR) of
2 W/kg for landmarks (i.e. center of RF coil) above the umbilicus
1 W/kg for landmarks below the umbilicus and above the mid-thigh
0.5 W/kg for landmarks below the mid-thigh
Under the scan conditions defined above, the Supera stent is expected to produce a maximum temperature rise of 7.6 C after 15 minutes of continuous scanning.
In nonclinical testing, the image artifact caused by the device extends approximately 2 cm from the Supera stent when imaged with a gradient echo or spin echo sequence and a 3T MRI system.
Potential Adverse Events: Potential adverse events include, but are not limited to:
Aneurysm or pseudoaneurysm in vessel or at vascular access site
Angina or coronary ischemia
Arrhythmia (including premature beats, bradycardia, atrial or ventricular tachycardia, atrial or ventricular fibrillation)
Arteriovenous fistula
Bleeding complications requiring transfusion or surgical intervention
Death
Detachment of a system component or implantation in an unintended site
Embolization, arterial or other (e.g. air, tissue, plaque, thrombotic material, or stent)
Emergent surgery
Fever
Hematoma or hemorrhagic event, with or without surgical repair
Hyperperfusion syndrome
Hypertension / Hypotension
Infection
Myocardial infarction
Pain (leg, foot, and/or insertion site)
Partial stent deployment
Peripheral nerve injury
Pulmonary embolism
Renal failure or insufficiency
Restenosis of vessel in stented segment
Shock
Stent malapposition or migration, which may require emergency surgery to remove stent
Stent strut fracture
Thrombosis or occlusion
Stroke
Transient ischemic attack
Venous thromboembolism
Vessel dissection, perforation or rupture
Vessel spasm or recoil
Worsening claudication or rest pain
MAT-2103597 v2.0
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
yes
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
[prod, crx3, samplecontent, publish, crx3tar]
test
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.